SEARCH

SEARCH BY CITATION

References

  • Alexanian, R., Dimopoulos, M.A., Hester, J., Delasalle, K. & Champlin, R. (1994) Early myeloablative therapy for multiple myeloma. Blood, 84, 42784282.
  • Alexanian, R., Weber, D., Giralt, S., Dimopoulos, M., Delasalle, K., Smith, T. & Champlin, R. (2001) Impact of complete remission with intensive therapy in patients with responsive multiple myeloma. Bone Marrow Transplantation, 27, 10371043.
  • Anderson, K.C., Andersen, J., Soiffer, R., Freedman, A.A., Rabinowe, S.N., Robertson, M.J., Spector, N., Blake, K., Murray, C., Freeman, A., Coral, F., Marcus, K.C., Mauch, P., Nauer, L.M. & Ritz, J. (1993) Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood, 82, 25682576.
  • Attal, M., Harousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. & Bataille, R. (1996) A prospective, randomised trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myeloma. New England Journal of Medicine, 335, 9197.
  • Attal, M., Harousseau, J.L., Facon, T., Guilhot, F., Doyen, C., Fuzibet, J.G., Monconduit, M., Hulin, C., Caillot, D., Bouabdallah, R., Voillat, L., Sotto, J.J., Grosbois, B. & Bataille, R. (2003) Single versus double autologous stem-cell transplantation for multiple myeloma. New England Journal of Medicine, 349, 24952502.
  • Barlogie, B., Hall, R., Zander, A., Dicke, K. & Alexanian, R. (1986) High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood, 67, 12981301.
  • Barlogie, B., Velasquez, W.S., Alexanian, R. & Cabanillas, F. (1989) Etoposide, dexamethasone, cytarabine and cisplatin in vincristine, doxorubicin and dexamethasone-refractory myeloma. Journal of Clinical Oncology, 7, 15141517.
  • Bensinger, W.I., Rowley, S.D., Demirer, T., Lilleby, K., Schiffman, K., Clift, R.A., Appelbaum, F.R., Fefer, A., Barnett, T., Storb, R., Chauncey, T., Maziarz, R.T., Klarnet, J., McSweeney, P., Holmberg, L., Maloney, D.G., Weaver, C.H. & Buckner, C.D. (1996) High-dose therapy followed by autologous haematopoietic stem-cell transplantation for patients with multiple myeloma. Journal of Clinical Oncology, 14, 14471456.
  • Blade, J., Samson, D., Reece, D., Apperley, J., Bjorkstrand, B., Gahrton, G., Gertz, M., Giralt, S., Jagannath, S. & Vesole, D. (1998) Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. British Journal of Haematology, 102, 11151123.
  • Cellini, C., Tosi, P., Zamagni, E., Cangini, D., Taccheti, P., Tura, S., Baccarani, M. & Cavo, M. (2003) Tolerance to long-term thalidomide therapy for patients with advanced and refractory multiple myeloma. The Hematology Journal, 4, 249 (abstract 360).
  • Child, J.A., Morgan, G.J., Davies, F.E., Owen, R.G., Bell, S.E., Hawkins, K., Brown, J., Drayson, M.T., Selby, P.J. & Medical Research Council Adult Leukaemia Working Party (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. New England Journal of Medicine, 348, 18751883.
  • Cunningham, D., Paz Ares, L., Milan, S., Powles, R., Nicholson, M., Hickish, T., Selby, P., Treleavan, J., Viner, C., Malpas, J., Slevin, M., Findlay, M., Raymond, J. & Gore, M.E. (1994) High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. Journal of Clinical Oncology, 12, 759763.
  • Dimopoulos, M.A., Weber, D.M., Hester, J., Delasalle, K., Champlin, R. & Alexanian, R. (1994) Intensive sequential therapy for VAD-resistant multiple myeloma. Leukemia and Lymphoma, 13, 479484.
  • Fermand, J.-P., Ravaud, P., Chevret, S., Divine, M., Leblond, V., Belanger, C., Macro, M., Pertuiset, E., Dreyfus, F., Mariette, X., Boccacio, C. & Brouet, J.-C. (1998) High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial. Blood, 92, 31313136.
  • Gertz, M.A., Lacy, M.Q., Inwards, D.J., Gastineau, D.A., Tefferi, A., Chen, M.G., Witzig, T.E., Greipp, P.R. & Litzow, M.R. (2000) Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma. Bone Marrow Transplantation, 26, 4550.
  • Harousseau, J.L., Attal, M., Divine, M., Marit, G., Leblond, V., Stoppa, A.M., Bourhis, A.H., Caillot, D., Boasson, M., Abgrall, J.F., Facon, T., Linassier, C., Cahn, J.-Y., Lamy, T., Troussard, X., Gratecos, N., Pignon, B., Auzanneau, B. & Bataille, R. (1995) Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on Autologous Transplantation in Multiple Myeloma. Blood, 85, 30773085.
  • Kropff, M.H., Lang, N., Bisping, G., Domine, N., Innig, G., Hentrich, M., Mitterer, M., Sudhoff, T., Fenk, R., Straka, C., Heinecke, A., Koch, O.M., Ostermann, H., Berdel, W.E. & Kienast, J. (2003) Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma. British Journal of Haematology, 122, 607616.
  • Lazzarino, M., Corso, A., Barbarano, L., Alessandrino, E.P., Cairoli, R., Pinotti, G., Ucci, G., Uziel, L., Rodeghiero, F., Fava, S., Ferrari, D., Fiumano, M., Frigerio, G., Isa, L., Luraschi, A., Montanara, S., Morandi, S., Perego, D., Santagostino, A., Savare, M., Vismara, A. & Morra, E. (2001) DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma. Bone Marrow Transplantation, 28, 835839.
  • Lee, C.K., Barlogie, B., Munshi, N., Zangari, M., Fassas, A., Jacobson, J., van Rhee, F., Cottler-Fox, M., Muwalla, F. & Tricot, G. (2003) DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma. Journal of Clinical Oncology, 21, 27322739.
  • Moehler, T.M., Neben, K., Benner, A., Egerer, G., Krasniqi, F., Ho, A.D. & Goldschmidt, H. (2001) Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy. Blood, 98, 38463848.
  • Peggs, K.S., Mackinnon, S., Williams, C.D., D'Sa, S., Thuraisundaram, D., Kyriakou, C., Morris, E.C., Hale, G., Waldmann, H., Linch, D.C., Goldstone, A.H. & Yong, K. (2003) Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity. Biology of Blood and Marrow Transplantation, 9, 257265.
  • Rajkumar, S.V., Fonseca, R., Lacy, M.Q., Witzig, T.E., Lust, J.A., Greipp, P.R., Therneau, T.M., Kyle, R.A., Litzow, M.R. & Gertz, M.A. (1999) Autologous stem cell transplantation for relapsed and primary refractory myeloma. Bone Marrow Transplantation, 12, 12671272.
  • Singhal, S., Powles, R., Sirohi, B., Treleaven, J., Kulkarni, S. & Mehta, J. (2002) Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma. Bone Marrow Transplantation, 30, 673679.
  • Velasquez, W.S., McLaughlin, P., Tucker, S., Hagemeister, F.B., Swan, F., Rodriguez, M.A., Romaguera, J., Rubenstein, E. & Cabanillas, F. (1994) ESHAP- an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. Journal of Clinical Oncology, 12, 11691176.
  • Vesole, D.H., Crowley, J.J., Catchatourian, R., Stiff, P.J., Johnson, D.B., Cromer, J., Salmon, S.E. & Barlogie, B. (1999) High-dose melphalan with autotransplantation for refractory multiple myeloma: results of a Southwest Oncology Group phase II trial. Journal of Clinical Oncology, 17, 21732179.
  • Weber, D., Rankin, K., Gavino, M., Delasalle, K. & Alexanian, R. (2003) Thalidomide alone or with dexamethasone for previously untreated multiple myeloma. Journal of Clinical Oncology, 21, 1619.
  • Zangari, M., Anaissie, E., Barlogie, B., Badros, A., Desikan, R., Gopal, A.V., Morris, C., Toor, A., Siegel, E., Fink, L. & Tricot, G. (2001) Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood, 98, 16141615.
  • Zangari, M., Barlogie, B., Anaissie, E., Saghafifar, F., Fassas, A., Lee, C.-K., Thertulien, R., van Rhee, F., Zeldis, J., Fink, L. & Tricot, G. (2002) Abrogation of thrombogenic effect of the doxorubicin-thalidomide combination as part of total therapy II for newly diagnosed multiple myeloma by effective anticoagulation with low molecular weight heparin. Blood, 100, 209a (abstract 1546).